MX2020011281A - Composicion farmaceutica topica para el tratamiento de fisuras anales y hemorroides. - Google Patents
Composicion farmaceutica topica para el tratamiento de fisuras anales y hemorroides.Info
- Publication number
- MX2020011281A MX2020011281A MX2020011281A MX2020011281A MX2020011281A MX 2020011281 A MX2020011281 A MX 2020011281A MX 2020011281 A MX2020011281 A MX 2020011281A MX 2020011281 A MX2020011281 A MX 2020011281A MX 2020011281 A MX2020011281 A MX 2020011281A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- hemorrhoids
- treatment
- topical pharmaceutical
- anal fissures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica tópica que va a usarse en la región anal para fisuras anales y hemorroides, incluyendo el periodo posoperatorio de hemorroidectomía. La composición farmacéutica comprende un dilatador anal, un polímero mucoadhesivo y un vehículo no acuoso. También se describe un método de fabricación de la composición farmacéutica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR102018008324-4A BR102018008324A2 (pt) | 2018-04-25 | 2018-04-25 | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
PCT/EP2019/060643 WO2019207059A1 (en) | 2018-04-25 | 2019-04-25 | Topical pharmaceutical composition for treatment of anal fissures and hemorrhoids |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020011281A true MX2020011281A (es) | 2020-11-13 |
Family
ID=66290462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020011281A MX2020011281A (es) | 2018-04-25 | 2019-04-25 | Composicion farmaceutica topica para el tratamiento de fisuras anales y hemorroides. |
Country Status (15)
Country | Link |
---|---|
US (1) | US11865207B2 (es) |
EP (1) | EP3784210B1 (es) |
JP (1) | JP2021522267A (es) |
KR (1) | KR20210005664A (es) |
CN (1) | CN112020349A (es) |
AU (1) | AU2019258677A1 (es) |
BR (2) | BR102018008324A2 (es) |
CA (1) | CA3098256C (es) |
CL (1) | CL2020002743A1 (es) |
CO (1) | CO2020014514A2 (es) |
DK (1) | DK3784210T3 (es) |
EA (1) | EA202092546A1 (es) |
LT (1) | LT3784210T (es) |
MX (1) | MX2020011281A (es) |
WO (1) | WO2019207059A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2019276832A1 (en) | 2018-06-01 | 2021-01-21 | Tavanta Therapeutics Hungary Incorporated | Topical amlodipine salts for the treatment of anorectal diseases |
RU2733080C1 (ru) * | 2019-12-13 | 2020-09-29 | Александр Евгеньевич Баранников | Фармакологическая композиция для лечения проктологических заболеваний (варианты). |
CN112691104A (zh) * | 2021-02-04 | 2021-04-23 | 刘泽陆 | 一种用于治疗痔疮的药物及其制备方法 |
CN115337258A (zh) * | 2022-07-22 | 2022-11-15 | 上海奥全生物医药科技有限公司 | 一种盐酸地尔硫卓的药物组合物、制备方法及其应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4118480A (en) * | 1973-02-09 | 1978-10-03 | Charles V. Stoelker | Pharmaceutical preparation for treating hemorrhoids and anal fissures |
JPS61212515A (ja) | 1985-03-16 | 1986-09-20 | Taisho Pharmaceut Co Ltd | 痔疾用軟膏 |
US6106856A (en) * | 1994-03-09 | 2000-08-22 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Transdermal delivery of calcium channel blockers, such as nifedipine |
GB9422571D0 (en) * | 1994-11-09 | 1995-01-04 | Whitehall Lab Ltd | Haemorrihoidal compositions and method of use |
AU733047C (en) * | 1997-02-24 | 2002-05-16 | S.L.A. Pharma Ag | Pharmaceutical composition |
US20030114394A1 (en) * | 2001-10-29 | 2003-06-19 | Levine Howard L. | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
US20080317679A1 (en) * | 2002-10-25 | 2008-12-25 | Foamix Ltd. | Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
US20040167479A1 (en) | 2003-02-20 | 2004-08-26 | The Procter & Gamble Company | Hemorrhoid treatment pad |
JPWO2005020960A1 (ja) | 2003-08-29 | 2007-11-01 | 佐藤製薬株式会社 | 直腸投与用製剤 |
CA2594718C (en) | 2005-01-14 | 2012-01-24 | Camurus Ab | Gnrh analogue formulations |
WO2007003204A1 (en) | 2005-07-06 | 2007-01-11 | Mahmoud Timour Mohamed Radwan | Topical formulation for the treatment of ano-rectal diseases |
US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
CN1771981A (zh) * | 2005-10-18 | 2006-05-17 | 夏运岳 | 一种痔疮膏 |
EP2432450B1 (en) | 2009-05-22 | 2019-07-31 | Wyeth LLC | Single-use, disposable strip for application of topical compositions |
RO126996B1 (ro) * | 2011-04-01 | 2013-03-29 | Klm Group S.R.L. | Cremă pentru tratamentul fisurilor anale şi procedeu de obţinere |
EP2958570A4 (en) | 2013-02-19 | 2016-07-20 | David Jonathan Hochman | THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PERIANAL DISORDERS |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
WO2016118040A1 (ru) * | 2015-01-21 | 2016-07-28 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий |
WO2017117268A1 (en) * | 2015-12-28 | 2017-07-06 | Hybrid Medical, Llc | Topical therapeutic formulations containing a calcium channel blocker, superoxide dismutase and emu oil |
-
2018
- 2018-04-25 BR BR102018008324-4A patent/BR102018008324A2/pt not_active Application Discontinuation
-
2019
- 2019-04-25 US US17/050,135 patent/US11865207B2/en active Active
- 2019-04-25 KR KR1020207033681A patent/KR20210005664A/ko unknown
- 2019-04-25 BR BR112020021572-4A patent/BR112020021572A2/pt unknown
- 2019-04-25 JP JP2020560249A patent/JP2021522267A/ja active Pending
- 2019-04-25 CN CN201980028394.2A patent/CN112020349A/zh active Pending
- 2019-04-25 EA EA202092546A patent/EA202092546A1/ru unknown
- 2019-04-25 CA CA3098256A patent/CA3098256C/en active Active
- 2019-04-25 AU AU2019258677A patent/AU2019258677A1/en active Pending
- 2019-04-25 WO PCT/EP2019/060643 patent/WO2019207059A1/en unknown
- 2019-04-25 LT LTEPPCT/EP2019/060643T patent/LT3784210T/lt unknown
- 2019-04-25 DK DK19719880.7T patent/DK3784210T3/da active
- 2019-04-25 MX MX2020011281A patent/MX2020011281A/es unknown
- 2019-04-25 EP EP19719880.7A patent/EP3784210B1/en active Active
-
2020
- 2020-10-22 CL CL2020002743A patent/CL2020002743A1/es unknown
- 2020-11-23 CO CONC2020/0014514A patent/CO2020014514A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
DK3784210T3 (da) | 2024-05-27 |
EP3784210B1 (en) | 2024-03-13 |
KR20210005664A (ko) | 2021-01-14 |
US11865207B2 (en) | 2024-01-09 |
LT3784210T (lt) | 2024-05-10 |
CL2020002743A1 (es) | 2021-01-15 |
JP2021522267A (ja) | 2021-08-30 |
WO2019207059A1 (en) | 2019-10-31 |
US20220151918A1 (en) | 2022-05-19 |
CA3098256C (en) | 2024-05-14 |
CN112020349A (zh) | 2020-12-01 |
BR102018008324A2 (pt) | 2019-11-05 |
BR112020021572A2 (pt) | 2021-01-19 |
EP3784210A1 (en) | 2021-03-03 |
CO2020014514A2 (es) | 2021-04-19 |
CA3098256A1 (en) | 2019-10-31 |
EA202092546A1 (ru) | 2021-03-02 |
AU2019258677A1 (en) | 2020-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020011281A (es) | Composicion farmaceutica topica para el tratamiento de fisuras anales y hemorroides. | |
CY1123845T1 (el) | Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων | |
MX359921B (es) | Métodos de tratamiento tópico para infecciones microbianas. | |
JOP20200315A1 (ar) | مركبات بورينون واستخدامها في معالجة السرطان | |
AU2015237050A8 (en) | Quinoline derivatives as SMO inhibitors | |
WO2018234568A3 (en) | HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION | |
MX2018003030A (es) | Acetamida tienotriazolodiazepinas y usos de las mismas. | |
MX2019014748A (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
MX2018001191A (es) | Geles de sellado, proceso para la produccion del mismo y uso del mismo en compuestos para el autosellado de llantas. | |
EP3623396A4 (en) | COMPOSITION OF BLOCK COPOLYMER OBTAINED BY MODIFICATION TREATMENT, PROCESS FOR THE PRODUCTION OF THE LATTER, COMPOSITION OF MODIFIED BLOCK COPOLYMER USED FOR THE LATTER, AND PROCESS FOR THE PRODUCTION OF SUCH COMPOSITION OF MODIFIED BLOCK COPOLYMER | |
MX2020012347A (es) | Inhibidor que contiene derivado triciclico, metodo de preparacion del mismo y aplicacion del mismo. | |
IN2013MU00711A (es) | ||
TR201821116A2 (tr) | POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ | |
EA201401031A1 (ru) | Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей | |
WO2016118040A8 (ru) | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий | |
CR20210507A (es) | Composición farmacéutica acuosa de anticuerpo anti-il17a y su uso | |
EP3739028A4 (en) | COMPOSITION CONTAINING OIL AND SOLID FATTY BODIES, ITS PRODUCTION PROCESS, PROCESS FOR ADJUSTING THE PHYSICAL PROPERTIES THEREOF, AND HARDENING AGENT FOR OIL AND FAT BODIES | |
BR112018073287A2 (pt) | composições cosméticas para reparação cutânea | |
AU2016298962A8 (en) | Compounds and pharmaceutical composition associated with ubiquitination-proteasome system | |
EA201890419A1 (ru) | ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ | |
DK1988909T3 (da) | Anvendelse af polyethylenglycol til inflammationsbeslægtede topiske lidelser eller sygdomme og sårheling | |
MY187986A (en) | Heteroatom containing modified diene polymers | |
WO2019036331A8 (en) | OSTEOPONTIN AS A TREATMENT OF NEURONAL INJURIES | |
BR112015014262A8 (pt) | formulação farmacêutica, dispositivo adaptado para distribuição intranasal de uma formulação farmacêutica, e, uso de uma formulação farmacêutica | |
NZ730267A (en) | Use of oxygen-enriched water composition |